Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 10X Genomics Inc (TXG) vs Advanced Drainage Systems Inc (WMS) Price & Performance

10X Genomics IncTrade
Advanced Drainage Systems IncTrade

Price performance (Past 24H)

Key statistics

10X Genomics Inc vs Advanced Drainage Systems Inc — how do they compare? 10X Genomics Inc trades at $80.53 (market cap $10.07B), while Advanced Drainage Systems Inc trades at $125 (market cap $9.52B). The key difference: 10X Genomics Inc and Advanced Drainage Systems Inc are close in size by market cap, and Advanced Drainage Systems Inc pays a 0.63% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 92 Days and Advanced Drainage Systems Inc for 43 Days on average.

TXGWMS
Market Cap
$10.07B$9.52B
Volume
5,657,286907,564
Sector
HealthBasic Materials
52-Week High
$97.74$175.38
52-Week Low
$11.48$125.33
Typical Hold Time
92 Days43 Days
Enterprise Value
$9.59B$11.12B
Dividend Yield
—0.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

10X Genomics Inc

TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.

The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.

Advanced Drainage Systems Inc

Advanced Drainage Systems (WMS) trades at $126.36, up 0.22% with a bearish technical signal despite strong fundamental performance. The company reported Q2 2026 EPS of $2.49, beating estimates by 18.6%, continuing a trend of earnings outperformance. Key financial metrics show robust profitability with 14% net income margin and 24.9% ROE, though cash flow turned negative in 2025 due to increased capital investments. Recent news highlights sustainability initiatives and institutional positioning changes.

WMS presents a compelling investment case with consistent earnings beats and strong analyst support ($188.70 price target), but faces near-term technical headwinds and cash flow pressures from aggressive expansion. The stock's current valuation at 21.5x P/E appears reasonable given growth prospects, though investors should monitor execution of NDS integration and capital allocation strategy.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TXG
4% Buy96% Sell
Avg holding period · 92 Days
WMS
100% Buy0% Sell
Avg holding period · 43 Days

Top news

Latest headlines on both assets

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →

About Advanced Drainage Systems Inc

Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe

Read more on WMS →